aTen Therapeutics
Pre-clinicalAugust 2022 aTen Therapeutics awarded £282k Innovate UK grant to develop new breast cancer treatment.
Founded
2021
Focus
AntibodiesBiologics
About
August 2022 aTen Therapeutics awarded £282k Innovate UK grant to develop new breast cancer treatment.
Funding History
2Total raised: $18.5M
Series A$15MEpidarex CapitalMay 15, 2023
Seed$3.5MEpidarex CapitalMar 15, 2021
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile